tiprankstipranks
Transgene SA (GB:0OCQ)
:0OCQ
UK Market

Transgene (0OCQ) Financial Statements

Compare
2 Followers

Transgene Financial Overview

Transgene's market cap is currently €94.35M. The company's EPS TTM is €-0.227; its P/E ratio is ―; Transgene is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 7.90M€ 3.13M€ 9.99M€ 2.98M€ 6.65M
Gross Profit€ -21.69M€ -29.04M€ -22.89M€ -24.36M€ -24.73M
Operating Income€ -30.05M€ -29.90M€ -23.52M€ -23.99M€ -25.45M
EBITDA€ -28.44M€ -28.21M€ -23.55M€ -20.44M€ -22.10M
Net Income€ -22.33M€ -32.81M€ -20.00M€ -18.45M€ -21.36M
Balance Sheet
Cash & Short-Term Investments€ 15.67M€ 26.83M€ 49.57M€ 26.35M€ 43.37M
Total Assets€ 45.22M€ 66.44M€ 101.84M€ 85.45M€ 115.48M
Total Debt€ 1.26M€ 2.45M€ 3.84M€ 5.28M€ 16.66M
Net Debt€ -14.41M€ -1.95M€ -2.07M€ 6.00K€ 15.32M
Total Liabilities€ 29.61M€ 28.59M€ 34.63M€ 35.20M€ 49.78M
Stockholders' Equity€ 15.61M€ 37.84M€ 67.21M€ 50.25M€ 65.70M
Cash Flow
Free Cash Flow€ -37.42M€ -21.84M€ -32.63M€ -29.59M€ -24.14M
Operating Cash Flow€ -34.67M€ -20.30M€ -31.94M€ -28.74M€ -22.41M
Investing Cash Flow€ 34.57M€ 20.27M€ 16.79M€ 17.74M€ -531.00K
Financing Cash Flow€ 11.37M€ -1.48M€ 15.77M€ 14.94M€ 22.40M
Currency in EUR

Transgene Earnings and Revenue History

Transgene Debt to Assets

Transgene Cash Flow

Transgene Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis